Former Roche exec to head EMD Millipore

Robert Yates, a 23-year veteran of Swiss life science giant Roche, has been tapped to lead Billerica, MA-based EMD Millipore, a provider of products and services for biotech R&D, as its president. Germany's Merck KGaA snapped up Millipore last year for $7 billion, according to Mass High Tech. Yates takes over at the EMD Millipore unit for Bernd Reckman, a Merck KGaA exec who took the helm at the life sciences company after the buyout. Report

Suggested Articles

Zentalis is coming out of stealth with an $85 million series C, which will propel its lead programs into pivotal trials and broaden its pipeline.

The planned takeover centers on ARQ 531, a BTK inhibitor that triggered durable responses in patients with B-cell malignancies.

At ASH, Dana-Farber researchers presented promising preclinical data on AMG 701, Amgen's long-lasting BiTE for multiple myeloma, but rivals loom.